Glucose transporter‐1 (GLUT‐1) expression in psoriasis: correlation with disease severity

Abstract Background Epidermal hyperproliferation with abnormal differentiation, inflammation, and angiogenesis are the key features of psoriasis. Glucose transporter‐1 ( GLUT ‐1) is a member of facilitative sugar transporters that are integral membrane glycoproteins moving sugar across cell membrane. Objective The objective of this study was to study the GLUT ‐1 expression in psoriasis. Patients and methods Forty patients with psoriasis vulgaris and 20 healthy individuals were included in the study. Skin biopsies were taken from lesional and nonlesional skin of psoriasis patients as well as normal skin of control subjects. All were examined for GLUT ‐1 antibody expression by immunohistochemistry and GLUT ‐1 mRNA expression by real‐time polymerase chain reaction (RT‐PCR). In addition, specimens of psoriasis lesions were stained by hematoxylin and eosin and CD 31 for morphometric analysis of histopathological parameters. Results The intensity of GLUT ‐1 immunohistochemical expression and the relative levels of GLUT ‐1 mRNA expression in psoriasis lesions were upregulated in lesional skin of psoriasis patients in comparison with their nonlesional skin as well as normal control skin. GLUT ‐1 expression in psoriasis lesions showed significant positive correlations with Psoriasis Area and Severity Index ( PASI ) score, mean of epidermal thickness, inflammatory cell density, and microvessel density. Conclusion Glucose transporter‐1 could play a role not only in the onset of psoriasis but also in the progression and severity of the disease. It may participate in the pathogenesis of psoriasis through the facilitation of epidermal hyperproliferation, inflammation, and angiogenesis.